- Home
- CIO vs AVIR Comparison
CIO vs AVIR Comparison
Compare CIO & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIO
- AVIR
- Stock Information
- Founded
- CIO 2013
- AVIR 2012
- Country
- CIO Canada
- AVIR United States
- Employees
- CIO N/A
- AVIR N/A
- Industry
- CIO Real Estate Investment Trusts
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- CIO Real Estate
- AVIR Health Care
- Exchange
- CIO Nasdaq
- AVIR Nasdaq
- Market Cap
- CIO 280.5M
- AVIR 290.4M
- IPO Year
- CIO 2014
- AVIR 2020
- Fundamental
- Price
- CIO $7.01
- AVIR $2.90
- Analyst Decision
- CIO Hold
- AVIR Hold
- Analyst Count
- CIO 1
- AVIR 1
- Target Price
- CIO N/A
- AVIR $6.00
- AVG Volume (30 Days)
- CIO 548.8K
- AVIR 297.2K
- Earning Date
- CIO 10-30-2025
- AVIR 11-06-2025
- Dividend Yield
- CIO 5.72%
- AVIR N/A
- EPS Growth
- CIO N/A
- AVIR N/A
- EPS
- CIO N/A
- AVIR N/A
- Revenue
- CIO $168,892,000.00
- AVIR N/A
- Revenue This Year
- CIO $0.60
- AVIR N/A
- Revenue Next Year
- CIO $3.53
- AVIR N/A
- P/E Ratio
- CIO N/A
- AVIR N/A
- Revenue Growth
- CIO N/A
- AVIR N/A
- 52 Week Low
- CIO $4.19
- AVIR $2.46
- 52 Week High
- CIO $7.01
- AVIR $4.02
- Technical
- Relative Strength Index (RSI)
- CIO 74.58
- AVIR 37.71
- Support Level
- CIO $6.93
- AVIR $2.78
- Resistance Level
- CIO $6.97
- AVIR $2.94
- Average True Range (ATR)
- CIO 0.02
- AVIR 0.11
- MACD
- CIO -0.01
- AVIR 0.01
- Stochastic Oscillator
- CIO 93.75
- AVIR 43.64
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).